^○Fumitaka Shimizu¹, Ryo Ogawa², Toshiyuki Takahashi², Yukio Takeshita¹, Tatsuro Misu², Yasuteru Sano¹, Toshihiko Maeda¹, Ichiro Nakashima³, Kazuo Fujihara⁴, Takashi Kanda¹ (1.Department of Neurology and Clinical Neuroscience, Yamaguchi University Graduate School of Medicine, Japan, 2.Department of Neurology, Tohoku University Graduate School of Medicine, 3.Department of Neurology, Tohoku Medical and Pharmaceutical University, 4.Department of Multiple Sclerosis Therapeutics, Fukushima Medical University)

^○Fumie Hayashi¹, Noriko Isobe², Jacob Glanville³, Guzailiayi Maimaitijiang¹, Takuya Matsushita¹, Jun-ichi Kira¹ (1.Department of Neurology, Graduate School of Medical Sciences, Kyushu University, Japan, 2.Department of Neurological Therapeutics, Graduate School of Medical Sciences, Kyushu University, 3.Computational and Systems Immunology Program, Stanford University School of Medicine)

^○Yuki Nakazato¹, Yuki Fujita², Toshihide Yamashita², Masamitsu Nakazato¹ (1.Department of Internal Medicine, Division of Neurology, Respirology, Endocrinology, and Metabolism, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Japan, 2.Department of Molecular Neuroscience, Graduate School of Medicine, Osaka University)

^○Ryo Yamasaki, Yinan Zhao, Satoshi Nagata, Yuko Nakamuta, Hiroo Yamaguchi, Jun-ichi Kira (Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Japan)

^○Yuji Nishimura¹, Katsuhisa Masaki¹, Dai Matsuse¹, Hiroo Yamaguchi¹, Toru Saiga¹, Tatsunori Tanaka¹, Mitsuru Watanabe¹, Ryo Yamasaki¹, Kenji Tanaka², Jun-ichi Kira¹ (1.Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Japan, 2.Department of Neuropsychiatry, School of Medicine, Keio University)

^○Norio Chihara, Ritsu Akatani, Shusuke Koto, Riki Matsumoto (Division of Neurology, Kobe University Graduate School of Medicine, Japan)

^○Ryohei Komaki, Norio Chihara, Takehiro Ueda, Kenji Sekiguchi, Riki Matsumoto (Division of Neurology. Kobe University Graduate School of Medicine, Japan)

^○Daiki Takewaki^1,2,3, Wakiro Sato^1,2, Wataru Suda⁴, Lena Takayasu^4,5, Naveen Kumar⁴, Toshiki Mizuno³, Sachiko Miyake⁶, Masahira Hattori⁴, Takashi Yamamura^1,2 (1.Department of Immunology, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Japan, 2.Multiple Sclerosis Center, National Center of Neurology and Psychiatry, Japan, 3.Department of Neurology, Kyoto Prefectural University of Medicine, Japan, 4.Laboratory for Microbiome Sciences, RIKEN Center for Integrative Medical Sciences, 5.School of International Health, Graduate School of Medicine, University of Tokyo, 6.Department of Immunology, Juntendo University School of Medicine)

^○Kaori Yanagawa¹, Mariko Hokari¹, Etsuji Saji¹, Fumihiro Yanagimura³, Takahiro Wakasugi¹, Masatoyo Nishizawa⁴, Osamu Onodera¹, Izumi Kawachi² (1.Department of Neurology, Brain Research Institute, Niigata University, Niigata, Japan, 2.Comprehensive Medical Education Center, Niigata University School of Medicine, Niigata, Japan, 3.Department of Neurology, NHO Niigata Hospital, Kashiwazaki, Japan, 4.Niigata University of Health and Welfare)

^○Hiroaki Yokote^1,2, Shuta Toru¹, Yoichiro Nishida², Takaaki Hattori², Nobuo Sanjo², Takanori Yokota² (1.Department of Neurology, Nitobe Memorial Nakano General Hospital, Japan, 2.Department of Neurology and Neurological Sciences, Tokyo Medical and Dental University, Japan)